These 10 Stocks Defied Tuesday’s Bloodbath

2. Genius Sports Ltd. (NYSE:GENI)

Genius Sports rallied by 11.9 percent on Tuesday to end at $9.31 apiece following the company’s strong earnings performance last year, coupled with an optimistic outlook from an analyst.

In a statement, GENI said its net loss in the full year of 2024 narrowed by 26 percent to $63 million from $85.5 million in 2023, while revenues increased by 24 percent to $510.9 million from $413 million year-on-year.

Meanwhile, net loss in the fourth quarter alone shrunk by 26 percent to $28 million from $38 million as revenues grew by 38 percent to $175 million from $127 million.

Following its earnings, Benchmark analyst Mike Hickey gave GENI a price target of $12 while maintaining its “buy” rating. The adjustment was based on the company’s strong earnings performance and future growth potential.